A nice place to discuss rumors, happenings, innovations, and challenges in the technology sphere. We also welcome discussions on the intersections of technology and society. If it’s technological news or discussion of technology, it probably belongs here.
Remember the overriding ethos on Beehaw: Be(e) Nice. Each user you encounter here is a person, and should be treated with kindness (even if they’re wrong, or use a Linux distro you don’t like). Personal attacks will not be tolerated.
Subcommunities on Beehaw:
This community’s icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.
🤖 I’m a bot that provides automatic summaries for articles:
Click here to see the summary
A statement (via CNBC) from the Office of US Trade Representative Katherine Tai said the agency “decided not to reverse the ITC’s [International Trade Commission] determination” after “careful consideration.”
The ITC issued the ban after finding that Apple infringed on blood oxygen saturation technology patented by a company called Masimo.
It also ordered Apple to stop selling any previously-imported devices with the infringed-upon tech.
While Apple attempted to block the decision while awaiting an appeal, the ITC denied Apple’s request, and the other chance of intervention was a veto from President Joe Biden, which didn’t happen.
Apple will also continue selling the Watch SE, as it doesn’t come with a blood oxygen sensor.
But both of those methods might not be enough to satisfy the ITC, which is why Apple could always choose to settle with Masimo instead.
Saved 47% of original text.